IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 127 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $454 | -35.4% | 100,000 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $703 | +15.2% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $610 | -3.0% | 100,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $629 | -99.9% | 100,000 | 0.0% | 0.00% | -33.3% |
| Q3 2022 | $942,000 | -29.3% | 100,000 | -19.3% | 0.00% | -25.0% |
| Q2 2022 | $1,333,000 | -35.6% | 123,900 | 0.0% | 0.00% | -20.0% |
| Q1 2022 | $2,069,000 | -4.7% | 123,900 | +10.0% | 0.01% | 0.0% |
| Q4 2021 | $2,171,000 | -28.9% | 112,600 | -11.8% | 0.01% | -44.4% |
| Q3 2021 | $3,055,000 | -8.6% | 127,600 | 0.0% | 0.01% | -10.0% |
| Q2 2021 | $3,343,000 | +77.5% | 127,600 | +100.6% | 0.01% | +66.7% |
| Q1 2021 | $1,883,000 | -38.3% | 63,600 | 0.0% | 0.01% | -45.5% |
| Q4 2020 | $3,054,000 | +241.6% | 63,600 | +128.8% | 0.01% | +175.0% |
| Q3 2020 | $894,000 | -63.7% | 27,800 | -74.5% | 0.00% | -66.7% |
| Q2 2019 | $2,462,000 | +54.9% | 109,000 | +21.1% | 0.01% | +33.3% |
| Q1 2019 | $1,589,000 | +451.7% | 90,000 | +176.9% | 0.01% | +350.0% |
| Q4 2018 | $288,000 | -81.9% | 32,500 | -63.9% | 0.00% | -77.8% |
| Q3 2018 | $1,589,000 | +32.7% | 90,000 | -2.6% | 0.01% | +12.5% |
| Q2 2018 | $1,197,000 | +71.0% | 92,400 | +117.9% | 0.01% | +60.0% |
| Q1 2018 | $700,000 | – | 42,400 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MHR Fund Management | 11,997,103 | $84,459,605 | 11.88% |
| MPM BioImpact LLC | 2,950,118 | $20,768,831 | 4.18% |
| Perceptive Advisors | 14,036,410 | $98,816,326 | 2.86% |
| Velan Capital Investment Management LP | 240,000 | $1,689,600 | 1.57% |
| Parametrica Management Ltd | 96,500 | $679,360 | 1.31% |
| Boxer Capital, LLC | 3,705,133 | $26,084 | 1.21% |
| Soleus Capital Management, L.P. | 1,239,777 | $8,728,030 | 0.97% |
| Opaleye Management Inc. | 421,000 | $2,963,840 | 0.71% |
| 683 Capital Management, LLC | 1,400,000 | $9,856,000 | 0.71% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,758,759 | $12,381,665 | 0.70% |